A gut infection pushed Parkinson's-risk mice into full motor decline — healthy mice were unaffected

Key Findings

🔬 A Gut Bacterium Is Linked to Lower Suicidal Ideation in Depression

• In 89 first-episode, drug-naive patients with major depressive disorder (compared to 52 healthy controls), shotgun metagenomic sequencing found that Bacteroides cellulosilyticus was enriched in healthy controls and showed a significant negative association with suicidal ideation severity.

• Among the depressed patients, 57 had suicidal ideation and 32 did not — and those with suicidal ideation showed reduced microbial capacity for peptidoglycan biosynthesis (a component of bacterial cell walls, relevant to immune signaling).

• Mediation analysis suggested B. cellulosilyticus may be linked to suicidal ideation through pathways involving carbohydrate metabolism, vitamin K2 production, and DNA repair — though this is associative, not causal.

💊 A Diabetes Drug Linked to Gut and Brain Protection in a Parkinson's Rat Model

• In rats given rotenone (a toxin used to model Parkinson's disease), treatment with canagliflozin — a diabetes drug (SGLT2 inhibitor) — was associated with improved motor function, reduced alpha-synuclein buildup in the brain, and lower markers of inflammation across 30 days.

• Rotenone-exposed rats showed gut microbiota shifts including enriched Parabacteroides and Ruminococcaceae and depleted Prevotella-related bacteria, along with a leakier gut lining and increased bacterial toxin (LPS) in the bloodstream — changes that were partially reversed by canagliflozin.

• The drug appeared to work by restoring gut microbial balance, reducing LPS leakage, and dampening the NLRP3 inflammasome (an immune signaling complex linked to brain inflammation) — though this is a rat model and human relevance is not yet established.

🧪 Stomach Surgery Improved Memory in Alzheimer's Mice — Without Weight Loss

• In APP/PS1/Tau triple-transgenic mice (a model of Alzheimer's disease), sleeve gastrectomy (stomach-reduction surgery) significantly improved cognitive performance and reduced anxiety-like behavior, along with lower buildup of a toxic tau protein in the hippocampus (the brain's memory center).

• Critically, these cognitive benefits appeared without lasting changes in body weight or food intake — suggesting the mechanism wasn't simply about weight loss.

• Surgery raised blood and brain levels of two gut hormones, GIP and GLP-1 (the same family targeted by drugs like semaglutide), and activated a brain signaling pathway (ERK/CREB/BDNF) linked to neuron survival; in cell experiments, blocking the GIP receptor worsened tau buildup.

🧠 Severe Autism Linked to More Disrupted Gut Bacteria Than Mild Autism

• In 81 children with autism spectrum disorder (ASD) aged 3–12, those with severe symptoms had significantly lower gut bacterial diversity than those with mild-to-moderate symptoms: Shannon index 3.82 vs. 4.04 (p = 0.047), and Simpson index 0.92 vs. 0.95 (p = 0.012).

• At the bacterial family level, severe ASD was associated with a rise in Enterobacteriaceae (4.64% → 13.08%) and a drop in several other families; at the genus level, Klebsiella increased nearly 3-fold (1.81% → 5.06%), while Faecalibacterium (linked to gut health) declined.

• This was a cross-sectional study with no healthy control group comparison for severity — so it can't establish whether gut changes drive symptom severity or the reverse.

🌊 A Seaweed-Derived Compound Reduced Depression-Like Behavior in Stressed Mice

• In mice subjected to 8 hours of daily restraint stress for 4–8 weeks (a model of chronic stress-induced depression), treatment with GV-971 — a marine oligosaccharide (a type of carbohydrate derived from seaweed, currently in trials for Alzheimer's) — reduced depression- and anxiety-like behaviors and restored hippocampal serotonin levels.

• GV-971 enriched beneficial gut bacteria (Bifidobacterium pseudolongum, Bacteroides uniformis), increased short-chain fatty acids (valeric and caproic acids), and reduced plasma levels of kynurenine and quinolinic acid — two compounds in the tryptophan pathway linked to depression and brain toxicity.

• Fecal transplants from GV-971-treated mice into stressed untreated mice partially reproduced the antidepressant and gut-protective effects, suggesting the remodeled gut microbiome plays a role — though this is an animal study.

👶 Probiotic and Prebiotic Supplements in Infants Show Gut Effects but Not Brain Effects

• A systematic review of 6 randomized controlled trials (1,148 infants randomized, 923 contributing data) found that probiotic and prebiotic interventions in babies aged 0–36 months selectively enriched Bifidobacterium and Lactobacillus and modestly increased secretory IgA (an immune protein in the gut lining) — but did not measurably change brain-relevant markers.

• Short-chain fatty acids, stress hormones (salivary cortisol), systemic inflammation markers, gut permeability, and neurodevelopmental outcomes showed no robust differences between intervention and control groups.

• The authors propose a concept they call "developmental neuroimmune gating" — the idea that in healthy infants, the gut-brain signaling pathway may be physiologically restricted from propagating local gut changes to the brain and nervous system during early life.